The Phoenix App for APOE4 carriers is here

Founding Member pricing ends when the apps go live. This is your last call.

3 Hidden Mechanisms of Tau-Driven Neurodegeneration revealed by Cambridge scientists

Phoenix: Last Call for Red Light Therapy Study and Lifetime membership + Our New App

Our new app for Supplements Insights releases next week

Your Gut Bacteria Controls Your Brain

and Why APOE4 Carriers Stand Apart

Join our research study: 1070nm Photobiomodulation with Neuronic and get your subsidized device

Save up to $645 on your Red Light Therapy device by participating in the study

Stanford achieves COMPLETE memory restoration in AD models by blocking metabolic switch + 75% patients have hidden sleep apnea (and it's consequences!)

Wednesday plenary from the AAIC, fresh from July 2025.

Simple Blood Test Detects Alzheimer's 15-20 Years Before Symptoms

P-tau217 + Other New Biomarkers

We're securing early pharma access for ApoE4 carriers, and more! (join before pricing changes)

The Phoenix in August: Patient Early Access Programs, subsidized Medtech devices, 80+ topics discussed

Cognitive reserve protects mood/behavior, not just memory

+ Insights on how to build your own cognitive reserve no matter your age.

Why Most APOE4 Interventions Lack Robust Scientific Evidence: A Candid Interview with Dr. Hussein Yassine on Clinical Trials, Supplements, and Self-Experimentation

Is Valiltramiprosate a Magic Pill for APOE4 carriers?

Great results for APOE4s, and a potential short term solution

4-year Alzheimer's trial data just dropped - 69% of early-stage patients showed zero decline

and there's finally good news for APOE4 carriers